Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001790340-25-000073

Options or other derivatives

  • Director acquired 33,350 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schall Thomas J. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-13 Grant or award : show line 1 in the form Stock Option +33,350 33,350 D
Loading xslF345X05/wk-form4_1750079729.xml…